Results 131 to 140 of about 36,527 (232)
Primary billiary cirrhosis (antimitochondrial antibody negative) leading to secondary amyloidosis [PDF]
A 49 years old lady presented with low-grade fever (99-100degreesF) for 2 years. During this time she was extensively worked-up for pyrexia of unknown origin but no diagnosis could be established.
Almas, Aysha, Parkash, Om
core +2 more sources
Murine models of Alzheimer’s disease (AD) are crucial for elucidating disease mechanisms but have limitations in fully representing AD molecular complexities.
Jay M. Yarbro +31 more
doaj +1 more source
Statistical Mechanics and Kinetics of Amyloid Fibrillation
Amyloid fibrillation is a protein self-assembly phenomenon that is intimately related to well-known human neurodegenerative diseases. During the past few decades, striking advances have been achieved in our understanding of the physical origin of this ...
Hong, Liu, Huang, Ya Jing, Lee, Chiu Fan
core +1 more source
Management of Proteinuria in Dogs and Cats with Chronic Kidney Disease [PDF]
Atkins +46 more
core +2 more sources
Reports from the Office of the Dean, Boston University School of ...
Office of the Dean, Boston University School of Medicine
core
Introduction: There is an unmet need to understand the mechanisms by which amyloid deposition drives alterations in the kidney. We leveraged renal biopsies from amyloid light-chain (AL) amyloidosis participants of the Renal AL Amyloid Involvement and ...
Cindy Varga +8 more
doaj +1 more source
Púrpura. Manifestação de Amiloidose Sistémica Primária [PDF]
Primary Systemic Amyloidosis (AL) is the most frequent form of systemic amyloidosis and its morbilility is associated with immunoglobulin light chains deposition in vital organs. The mucocutaneous manifestations occur in about 30-40% of the cases and are
Apetato, M +4 more
core
Molecular Mechanisms of Cardiac Amyloidosis
Cardiac involvement has a profound effect on the prognosis of patients with systemic amyloidosis. Therapeutic methods for suppressing the production of causative proteins have been developed for ATTR amyloidosis and AL amyloidosis, which show cardiac involvement, and the prognosis has been improved.
openaire
AL amyloidosis: from molecular mechanisms to targeted therapies.
G. Merlini
semanticscholar +1 more source
Apolipoprotein E and Alzheimer’s disease: The influence of apolipoprotein E on amyloid- and other amyloidogenic proteins [PDF]
Agosta +207 more
core +2 more sources

